KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Current Taxes (2016 - 2025)

Merck (MRK) has disclosed Current Taxes for 17 consecutive years, with $4.7 billion as the latest value for Q4 2025.

  • Quarterly Current Taxes rose 20.75% to $4.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.7 billion through Dec 2025, up 20.75% year-over-year, with the annual reading at $4.7 billion for FY2025, 20.75% up from the prior year.
  • Current Taxes for Q4 2025 was $4.7 billion at Merck, down from $4.8 billion in the prior quarter.
  • The five-year high for Current Taxes was $5.2 billion in Q1 2025, with the low at $954.0 million in Q3 2021.
  • Average Current Taxes over 5 years is $2.6 billion, with a median of $2.0 billion recorded in 2022.
  • The sharpest move saw Current Taxes decreased 23.36% in 2021, then surged 118.58% in 2024.
  • Over 5 years, Current Taxes stood at $1.2 billion in 2021, then surged by 62.25% to $2.0 billion in 2022, then soared by 33.38% to $2.6 billion in 2023, then skyrocketed by 47.75% to $3.9 billion in 2024, then rose by 20.75% to $4.7 billion in 2025.
  • According to Business Quant data, Current Taxes over the past three periods came in at $4.7 billion, $4.8 billion, and $4.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.